NCT06676488View on ClinicalTrials.gov

A Randomized Crossover Trial of Bright Light Therapy in Irritable Bowel Syndrome

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 11, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Irritable Bowel Syndrome (IBS)Circadian Misalignment
Interventions
DEVICE

Re-Timer glasses

Morning bright light therapy (BLT) will be administered through a safe wearable glasses device called a Re-Timer, purchased from the manufacturer Re-Timer.

DEVICE

Placebo Device

Placebo glasses not providing Bright Light Therapy

Trial Locations (1)

29425

RECRUITING

Medical University of South Carolina, Charleston

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Medical University of South Carolina

OTHER

NCT06676488 - A Randomized Crossover Trial of Bright Light Therapy in Irritable Bowel Syndrome | Biotech Hunter | Biotech Hunter